TEM vs GH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GH Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Guardant Health, Inc. Common Stock (GH) driven by superior Momentum & Technical, Options & Structure while TEM counters with relative strength in Growth & Margin. Fundamentally, TEM trades at N/M Forward P/E with -18.5% operating margin (+23.1% YoY revenue) versus GH at N/M Forward P/E and -39.4% operating margin (+36.1% YoY). In options structure, TEM sits in BREAKDOWN (44th %ile IV; Dealer Gamma Walls on Pro) against GH sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TEM Revenue | GH Revenue | TEM Op. Margin | GH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $90M | N/A | -102.5% | GH |
| FY2019 | N/A | $210M | N/A | -38.4% | GH |
| FY2020 | N/A | $290M | N/A | -88.9% | GH |
| FY2021 | N/A | $370M | N/A | -110.0% | GH |
| FY2022 | $320M | $450M | -82.8% | -121.1% | TEM |
| FY2023 | $530M | $560M | -36.9% | -100.1% | TEM |
| FY2024 | $690M | $740M | -99.7% | -60.0% | GH |
| FY2025 | $1.27B | $980M | -19.9% | -44.5% | TEM |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TEM | GH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.1B | $20.5B | Larger Scale | GH |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +23.1% | +36.1% | Higher Growth | GH |
| Operating Margin (TTM) Profitability | -18.5% | -39.4% | Higher Margin | TEM |
| Net Profit Margin Profitability | -12.5% | -37.9% | Higher Margin | TEM |
| Return on Equity (ROE) Capital Efficiency | -37.5% | 0.0% | Higher ROE | GH |
| 52-Week Range Position Momentum | 46% ($41โ$89) | 60% ($75โ$191) | Stronger Trend | GH |
| Beta / 30D Volatility Risk Regime | 2.51ฮฒ ยท 93% Vol | 1.31ฮฒ ยท 55% Vol | Lower Realized Risk | GH |
| Unified Institutional Score Composite Signal | 43.5 / 100 (HOLD) | 51.3 / 100 (HOLD) | Higher Composite | GH |